ترقية الحساب

Neuroprosthetics Market Set to Revolutionize Neural Health, Targets USD 26.12 Billion by 2030 | SNS Insider

Neuroprosthetics Market Trends and Overview

The Neuroprosthetics Market was valued at USD 10.40 billion in 2022 and is projected to reach USD 26.12 billion by 2030, with a compound annual growth rate (CAGR) of 12.2% during the forecast period from 2023 to 2030.

Neuroprosthetics, a rapidly expanding field, encompasses the development and application of prosthetic devices that interface with the nervous system. These innovative technologies aim to restore or enhance the functionality of individuals suffering from neurological disorders or injuries.

The market's remarkable growth can be attributed to several factors. Firstly, the increasing prevalence of neurological disorders, such as Parkinson's disease, epilepsy, and spinal cord injuries, has created a pressing need for advanced treatment options. Neuroprosthetics offer promising solutions by bridging the gap between the nervous system and artificial devices, enabling patients to regain lost functionalities.

Furthermore, advancements in technology have paved the way for more sophisticated neuroprosthetic devices. The integration of artificial intelligence, machine learning, and robotics has revolutionized the field, allowing for more precise and personalized treatments. These cutting-edge technologies have significantly improved the efficacy and safety of neuroprosthetics, driving their adoption across various healthcare settings.

Moreover, the rising geriatric population, coupled with the growing awareness about neuroprosthetic treatments, has fueled market growth. As the elderly population is more susceptible to neurological disorders, the demand for effective interventions has surged. Additionally, increased investments in research and development activities have accelerated the pace of innovation, leading to the introduction of novel neuroprosthetic solutions.

Geographically, North America currently dominates the neuroprosthetics market, owing to the region's robust healthcare infrastructure and substantial investments in research and development. However, the Asia Pacific region is expected to witness significant growth during the forecast period, driven by the rising healthcare expenditure, expanding patient pool, and increasing awareness about neuroprosthetic treatments.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2882

KEY MARKET SEGMENTATION:

By Type

  • Output neural prosthetics
  • Input neural prosthetics

By Technique

  • Spinal Cord Stimulation  
  • Deep Brain stimulation
  • Vagus Nerve stimulation
  • Sacral nerve Stimulation
  • Transcranial Magnetic Stimulation

By Application

  • Motor neurons disorders
  • Physiological disorders
  • Cognitive disorders

Major Players Listed in the Report are as Follows:

Medtronic plc, Cochlear Ltd, Boston Scientific, Abbott laboratories, LivaNova, Retina implant Ag, Sonova, Neuropace, Second Sight medical products, Nevro, MED-EL and others.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com